(Q37609232)

21 August 2017

title

Fixed and flexible formularies as cost-control mechanisms (English)

1 reference

21 August 2017

Jeffrey S Hoch

2

0 references

Carolyn S Dewa

series ordinal

1

object named as

Carolyn S Dewa

1 reference

21 August 2017

language of work or name

1 reference

1 June 2003

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

21 August 2017

published in

1 reference

21 August 2017

volume

3

1 reference

21 August 2017

issue

3

1 reference

21 August 2017

page(s)

303-315

1 reference

Just what the HMO ordered: the paradox of increasing drug costs

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.3.303

The menu-setting problem and subsidized prices: drug formulary illustration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.3.303

The demand for prescription drugs as a function of cost-sharing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.3.303

Access and cost implications of state limitations on Medicaid reimbursement for pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.3.303

Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.3.303

Financial incentives and drug spending in managed care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.3.303

Effect of a three-tier prescription copay on pharmaceutical and other medical utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.3.303

Pharmacy benefit management companies: dimensions of performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.3.303

21 January 2018

Identifiers

DOI

10.1586/14737167.3.3.303

1 reference

21 August 2017

1 reference